The global diabetes market, including drugs and devices, increased by 36% from 2006 to 2009, to reach a stunning $34 billion in 2009, compared to ~ $25 billion in 2006 and just over $18 billion in 2004.
The market has nearly doubled in five years, and despite the upcoming expirations of major patents and pricing pressure in self monitoring blood glucose, the growth will continue to spiral.
How could it not, given the sheer size of the diabetes population, the number of untreated and undertreated patients, the number of new diagnoses each day?
No comments:
Post a Comment